Background: The autologous noncultured melanocyte keratinocyte transplant procedure (MKTP) has emerged as a popular grafting technique with proven efficacy for achieving repigmentation. However, there remains no consensus regarding the optimal recipient-to-donor (RD) ratio required to achieve acceptable repigmentation. In this retrospective cohort study of 120 patients, we sought to examine whether expansion ratios impact the repigmentation success rates following MKTP. Results: A total of 69 patients (mean [SD] age was 32.4 [14.3] years, mean follow-up was 30.4 [22.5] months, 63.8% were male; 55% were dark-skinned individuals [Fitzpatrick IV–VI]) were included. The mean percent change in the Vitiligo Area Scoring Index (VASI) was 80.2 (±23.7; RD of 7.3) in patients with focal/segmental vitiligo (SV), 58.3 (±33.0; RD of 8.2) in those with non-segmental vitiligo (NSV), and 51.8 (±33.6; RD of 3.7) in those with leukoderma and piebaldism. Focal/SV was positively associated with a higher percent change in VASI (parameter estimate: 22.6, p value <0.005). In the SV/focal group, non-white patients had a higher RD ratio compared to White individuals (8.2 ± 3.4 vs. 6.0 ± 3.1, respectively, p value = 0.035). Discussion: In our study, we found that patients with SV were significantly more likely to achieve higher repigmentation rates compared to those with NSV. Although repigmentation rates were higher in the low expansion ratio group than in the high expansion ratio group, we did not observe a significant difference between the two groups. Conclusion: MKTP is an effective therapy for restoring repigmentation in patients with stable vitiligo. Therapeutic response of vitiligo to MKTP appears to be influenced by the type of vitiligo, rather than a specific RD ratio.

1.
Bergqvist
C
,
Ezzedine
K
.
Vitiligo: a review
.
Dermatology
.
2020
;
236
(
6
):
571
92
.
2.
Vakharia
PP
,
Lee
DE
,
Khachemoune
A
.
Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence
.
Int J Dermatol
.
2018
;
57
(
7
):
770
5
.
3.
Silpa-Archa
N
,
Griffith
JL
,
Huggins
RH
,
Henderson
MD
,
Kerr
HA
,
Jacobsen
G
.
Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas
.
J Am Acad Dermatol
.
2017
;
77
(
2
):
318
27
.
4.
Hong
WS
,
Hu
DN
,
Qian
GP
,
McCormick
SA
,
Xu
AE
.
Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation
.
Br J Dermatol
.
2011
;
165
(
3
):
520
5
.
5.
Narayan
VS
,
van den Bol
LLC
,
van Geel
N
,
Bekkenk
MW
,
Luiten
RM
,
Wolkerstorfer
A
.
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review
.
J Eur Acad Dermatol Venereol
.
2021
;
35
(
5
):
1077
86
.
6.
Mulekar
SV
.
Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation
.
Arch Dermatol
.
Oct 2004
140
10
1211
5
.
7.
van Geel
N
,
Wallaeys
E
,
Goh
BK
,
De Mil
M
,
Lambert
J
.
Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus
.
Br J Dermatol
.
2010
;
163
(
6
):
1186
93
.
8.
Speeckaert
R
,
Lambert
J
,
Bulat
V
,
Belpaire
A
,
Speeckaert
M
,
van Geel
N
.
Autoimmunity in segmental vitiligo
.
Front Immunol
.
2020
;
11
:
568447
.
You do not currently have access to this content.